[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"condition:nasopharyngeal-non-keratinizing-carcinoma":3},{"name":4,"total":5,"recruiting":6,"trials":7,"biomarkers":16,"states":17},"Nasopharyngeal Non-Keratinizing Carcinoma",1,0,[8],{"nct_id":9,"title":10,"phases":11,"status":13,"updated_at":14,"content_modified":15},"NCT07650266","A Study of Cemiplimab and Fianlimab in People With Nasopharyngeal Carcinoma",[12],"Phase 1","NOT_YET_RECRUITING","2026-08-26T02:15:52.238965Z","2026-06-17T02:29:30.061545Z",[],[]]